Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CNR2 | P34972 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425873 | 0.83 | HDAC8 (0.61) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL699925 | 0.81 | MEN1 (0.71) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL7107935 | 0.81 | ALDH1A1 (0.77) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL743447 | 0.80 | MEN1 (0.42) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL8313887 | 0.80 | CA2 (0.56) | LMNARAB9A | |
| Phenylacetohydroxamic Acid SCHEMBL213873 | 0.79 | HDAC8 (1.00) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL27663467 | 0.78 | MEN1 (0.61) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL9199661 | 0.78 | CES2 (0.42) | MEN1KMT2AHDAC8HDAC6EPHX2 | |
| SCHEMBL3369337 | 0.78 | GAA (0.63) | MEN1KMT2AALDH1A1GAALMNA | |
| SCHEMBL6244676 | 0.78 | LMNA (0.59) | MEN1KMT2AALDH1A1CNR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11939404-B2 | Method for producing cyclized peptide having intramolecular S-S bond | AJINOMOTO CO., INC. (JP) | 2024-03-26 | — | — | US | claimed |
| CN-116675731-A | Small molecule conjugate of targeted cyclin-dependent kinase 12/13 and application thereof | 浙江大学 | 2023-09-01 | — | — | CN | claimed |
| EP-3882255-A1 | METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND | AJINOMOTO CO., INC. (JP) | 2021-09-22 | — | — | EP | claimed |
| US-20210277063-A1 | METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND | AJINOMOTO CO., INC. (JP) | 2021-09-09 | — | — | US | claimed |
| CN-113039193-A | Method for producing cyclized peptide having intramolecular S-S bond | 味之素株式会社 | 2021-06-25 | — | — | CN | claimed |
| EP-3110828-B1 | CONTINUOUS FLOW PEPTIDE SYNTHESIS | UNIV SZEGEDI (HU) | 2020-12-09 | — | — | EP | claimed |
| US-10577459-B2 | Aliphatic poly(ester)s with thiol pendant groups | WISTRAND, Anna (SE) | 2020-03-03 | — | — | US | claimed |
| US-20180305495-A1 | ALIPHATIC POLY(ESTER)S WITH THIOL PENDANT GROUPS | PAPPALARDO, Daniela (IT) | 2018-10-25 | — | — | US | claimed |
| EP-3362500-A1 | ALIPHATIC POLY(ESTER)S WITH THIOL PENDANT GROUPS | Novus Scientific AB (SE) | 2018-08-22 | — | — | EP | claimed |
| EP-2800756-B1 | PEPTIDE C ALPHA-AMIDES, METHODS FOR PREPARING SAME AND USES THEREOF AS PRECURSORS OF PEPTIDE C ALPHA-THIOESTERS FOR PROTEIN SYNTHESIS | CENTRE NAT RECH SCIENT (FR) | 2018-04-25 | — | — | EP | claimed |
| CN-1034663-C | Method for preparing blood regulation peptide | SMITHKLINE BEECHAM CORP (US) | 1997-04-23 | — | — | CN | claimed |
| EP-0621788-A4 | HEMOREGULATORY PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0671931-A4 | HEMOREGULATORY PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1995-11-22 | — | — | EP | claimed |
| EP-0671931-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-09-20 | — | — | EP | claimed |
| EP-0621788-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-02 | — | — | EP | claimed |
| EP-0408371-B1 | Hemoregulatory peptides | SMITHKLINE BEECHAM CORP (US) | 1994-09-28 | — | — | EP | claimed |
| WO-1993013789-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |
| WO-1993010807-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-10 | — | — | WO | claimed |
| CN-1054773-A | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1991-09-25 | — | — | CN | claimed |
| EP-0408371-A1 | Hemoregulatory peptides | SMITHKLINE BEECHAM CORPORATION (US) | 1991-01-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939404-B2 | Method for producing cyclized peptide having intramolecular S-S bond | SPPL2B, PTMS, VIP | MEN1 844/4885KMT2A 4316/4885HDAC8 4004/4885 |
| US-10577459-B2 | Aliphatic poly(ester)s with thiol pendant groups | PARG, TST, CBS | MEN1 3136/4885KMT2A 2225/4885HDAC8 2791/4885 |
| US-20210277063-A1 | METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND | SPPL2B, PTMS, VIP | MEN1 844/4885KMT2A 4316/4885HDAC8 4004/4885 |
| US-20180305495-A1 | ALIPHATIC POLY(ESTER)S WITH THIOL PENDANT GROUPS | PARG, TST, CBS | MEN1 3136/4885KMT2A 2225/4885HDAC8 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.